How much funding has Mendra raised?

Mendra has raised $82.0M in total funding, most recently a Series A round.

Who are Mendra's investors?

Mendra's investors include OrbiMed, 8VC, 5AM Ventures, Lux Capital, Wing VC.

Where is Mendra headquartered?

Mendra is headquartered in San Francisco, California, United States.

What industry is Mendra in?

Mendra operates in Artificial Intelligence, Biotech, Healthcare.

Mendra

Advancing rare disease medicines through AI

San Francisco, United States · Founded 2026 · $82.0M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: San Francisco, California
Employees: 1–10
Founded: 2026
Business Model: B2B

Website: mendra.com
Total Funding: $82.0M
Last Round: $82.0M Series AJan 2026
Rounds: 1

About

Mendra is a biopharmaceutical company founded by veterans of BioMarin Pharmaceutical and Escient Pharmaceuticals to modernize rare disease drug development. The company leverages artificial intelligence to address long-standing challenges in patient identification, clinical trial enrollment, data curation, and global commercialization for diseases with high unmet medical need. Mendra plans to acquire and develop rare disease assets, combining deep domain expertise with AI-driven capabilities across asset selection, clinical development, and global commercialization to accelerate access to innovative treatments for underserved patient populations. The company launched in January 2026 with an $82 million Series A co-led by OrbiMed, 8VC, and 5AM Ventures with participation from Lux Capital and Wing VC.

Summary

Mendra is an Artificial Intelligence company based in San Francisco, United States, founded in 2026. It has raised $82.0M in total across 1 round, most recently a $82.0M Series A round in Jan 2026. Investors include OrbiMed, 8VC and 5AM Ventures.